TORL BioTherapeutics, LLC
Andrew Romero currently serves as the Director of Clinical Operations at TORL BioTherapeutics, LLC, since October 2023. Previously, Andrew held positions at Kite Pharma, where responsibilities included managing Phase 1 and Phase 2 cell therapy clinical trials and handling internal audit findings, and City of Hope, focusing on oncology research coordination for various clinical trials. Andrew's experience encompasses regulatory compliance, patient safety, and study startup processes. In earlier roles, Andrew contributed to environmental consulting at Amec Foster Wheeler and research assistance at the Scripps Institution of Oceanography. Andrew holds a Bachelor’s Degree in Marine Biology from UC San Diego and is actively engaged in self-education within the pharma and biotech sectors.
This person is not in any teams
This person is not in any offices
TORL BioTherapeutics, LLC
1 followers
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers